Targacept Depression Drug Hits the Mark
One patient reported a seizure that was deemed by investigators to be related to either Celexa or TC-5214.
Targacept said it was actively seeking a partner to further the development of TC-5214, with phase III studies to start in the second quarter 2010. Targacept shares were up 87.3% to $5.73 in recent trading.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,328.89 | 1,102.47 | 2,211.69 | 35.46 |
Oil *
73.88
|
|
UP
20.63
|
UP
6.40
|
UP
31.64
|
UP
0.59
|
10 Yr
3.55%
SPDR Gold
108.95
|
|
+0.20%
|
+0.58%
|
+1.45%
|
+1.69%
|
Data delayed 20 minutes |
